Raynaud’s Phenomenon and Environmental Chemicals
Raynaud’s phenomenon—episodic vasospasm of fingers and toes triggered by cold or stress—affects approximately 5% of the population. Primary Raynaud’s occurs without underlying disease; secondary Raynaud’s is associated with autoimmune conditions. Chemical exposures affecting vascular endothelial function may influence Raynaud’s severity and prevalence.
PFAS and Endothelial Vasomotor Function
PFAS impair endothelial nitric oxide synthase activity, reducing vascular nitric oxide production that normally maintains vasodilation and prevents vasospasm. Impaired NO-mediated vasodilation increases sensitivity to vasoconstrictive stimuli—cold temperature, stress hormones—that trigger Raynaud’s attacks in susceptible individuals.
Chemical Exposure and Raynaud’s Associations
Occupational cohort studies of fluorochemical workers show higher rates of Raynaud’s phenomenon than unexposed reference populations. Community studies in PFAS-contaminated areas document elevated Raynaud’s prevalence, though distinguishing PFAS effects from other vascular risk factor confounders remains challenging in observational studies.
Rheumatology and Vascular Medicine
Clinicians evaluating Raynaud’s phenomenon—particularly secondary Raynaud’s in patients without clear autoimmune disease—should consider PFAS environmental exposure history. Reducing PFAS exposure may modestly improve endothelial function and reduce vasospasm frequency in PFAS-sensitized individuals.